Knuff & Co’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.23M | Buy |
13,996
+171
| +1% | +$76.1K | 1.96% | 17 |
|
2025
Q1 | $6.7M | Sell |
13,825
-116
| -0.8% | -$56.2K | 2.25% | 13 |
|
2024
Q4 | $5.61M | Sell |
13,941
-252
| -2% | -$101K | 1.71% | 17 |
|
2024
Q3 | $6.6M | Sell |
14,193
-150
| -1% | -$69.8K | 2.01% | 16 |
|
2024
Q2 | $6.72M | Sell |
14,343
-7
| -0% | -$3.28K | 2.18% | 13 |
|
2024
Q1 | $6M | Buy |
14,350
+169
| +1% | +$70.6K | 2.02% | 16 |
|
2023
Q4 | $5.77M | Sell |
14,181
-251
| -2% | -$102K | 2.1% | 16 |
|
2023
Q3 | $5.02M | Sell |
14,432
-168
| -1% | -$58.4K | 2% | 16 |
|
2023
Q2 | $5.14M | Sell |
14,600
-380
| -3% | -$134K | 1.93% | 15 |
|
2023
Q1 | $4.72M | Sell |
14,980
-1,173
| -7% | -$370K | 1.87% | 16 |
|
2022
Q4 | $4.66M | Sell |
16,153
-71
| -0.4% | -$20.5K | 1.99% | 15 |
|
2022
Q3 | $4.7M | Sell |
16,224
-1,063
| -6% | -$308K | 2.22% | 13 |
|
2022
Q2 | $4.87M | Sell |
17,287
-375
| -2% | -$106K | 2.19% | 13 |
|
2022
Q1 | $4.61M | Buy |
17,662
+16
| +0.1% | +$4.18K | 1.67% | 17 |
|
2021
Q4 | $3.88M | Buy |
17,646
+634
| +4% | +$139K | 1.2% | 27 |
|
2021
Q3 | $3.09M | Buy |
17,012
+134
| +0.8% | +$24.3K | 1.15% | 29 |
|
2021
Q2 | $3.4M | Buy |
16,878
+105
| +0.6% | +$21.2K | 1.26% | 29 |
|
2021
Q1 | $3.6M | Buy |
16,773
+44
| +0.3% | +$9.45K | 1.54% | 24 |
|
2020
Q4 | $3.95M | Buy |
16,729
+6,700
| +67% | +$1.58M | 1.63% | 23 |
|
2020
Q3 | $2.73M | Buy |
10,029
+1,084
| +12% | +$295K | 1.28% | 26 |
|
2020
Q2 | $2.6M | Buy |
8,945
+753
| +9% | +$219K | 1.42% | 24 |
|
2020
Q1 | $1.95M | Sell |
8,192
-16
| -0.2% | -$3.81K | 1.42% | 22 |
|
2019
Q4 | $1.8M | Buy |
8,208
+693
| +9% | +$152K | 1.07% | 29 |
|
2019
Q3 | $1.27M | Buy |
7,515
+1,015
| +16% | +$172K | 0.88% | 29 |
|
2019
Q2 | $1.19M | Buy |
6,500
+425
| +7% | +$77.9K | 0.85% | 29 |
|
2019
Q1 | $1.12M | Buy |
6,075
+460
| +8% | +$84.6K | 0.86% | 28 |
|
2018
Q4 | $930K | Buy |
+5,615
| New | +$930K | 0.91% | 28 |
|